INHALATION OF LEVOFLOXACIN FOR REDUCING LUNG INFLAMMATION

Title:

INHALATION OF LEVOFLOXACIN FOR REDUCING LUNG INFLAMMATION

Document Type and Number:

Japanese Patent JP2015044825

Kind Code:

A

Abstract:

PROBLEM TO BE SOLVED: To provide methods and compositions for the treatment of pulmonary inflammation.SOLUTION: The present invention provides, in particular, methods and compositions using aerosol levofloxacin or ofloxacin to reduce pulmonary inflammation.

Inventors:

DUDLEY MICHAEL N
RUSLAN Y TSIVKOVSKI
GRIFFITH DAVID C
OLGA RODNY

Application Number:

JP2014208156A

Publication Date:

March 12, 2015

Filing Date:

October 09, 2014

Export Citation:

Click for automatic bibliography generation Help

Assignee:

MPEX PHARMACEUTICALS INC

International Classes:

A61K31/5383; A61K9/12; A61K45/00; A61K47/02; A61P7/02; A61P11/00; A61P11/06; A61P11/08; A61P29/00; A61P35/00; A61P43/00

Foreign References:

WO2006125132A2

2006-11-23

Other References:

JPN5012003081; ＣＡＬＢＯ　ＥＳＴＨＥＲ: 'ＳＹＳＴＥＭＩＣ　ＥＸＰＲＥＳＳＩＯＮ　ＯＦ　ＣＹＴＯＫＩＮＥ　ＰＲＯＤＵＣＴＩＯＮ　ＩＮ　ＰＡＴＩＥＮＴＳ　ＷＩＴＨ　ＳＥＶＥＲＥ　ＰＮＥＵＭＯＣＯＣＣＡＬ　ＰＮＥＵＭＯＮＩＡ：　以下備考' ＡＮＴＩＭＩＣＲＯＢＩＡＬ　ＡＧＥＮＴＳ　ＡＮＤ　ＣＨＥＭＯＴＨＥＲＡＰＹＶ５２　Ｎ７, 200807, Ｐ２３９５-２４０２
JPN6016023758; ＲｅｓｐｉｒｏｌｏｇｙＶｏｌ．１３, 200801, ｐ．４７-５２
JPN6016023760; ＲｅｓｐｉｒｏｌｏｇｙＶｏｌ．１３, 200801

Attorney, Agent or Firm:

Yasuhiko Murayama
Masatake Shiga
Takashi Watanabe
Shinya Jitsuhiro

Previous Patent: METHODS FOR TREATING MULTIPLE SCLEROSIS USING ANTISENSE OLIGONUCLEOTIDES

Next Patent: YopM AS DELIVERY VEHICLE FOR CARGO MOLECULES AND AS BIOLOGICAL THERAPEUTIC FOR IMMUNOMODULATION OF I...